LIGAND PHARMACEUTICALS INC 4
4 · LIGAND PHARMACEUTICALS INC · Filed Dec 2, 2003
Insider Transaction Report
Form 4
JOHNSON IRVING S
Director
Transactions
- Exercise/Conversion
Common Stock
2003-12-01$9.21/sh+2,494$22,971→ 25,423 total - Sale
Common Stock
2003-12-01$13.88/sh−2,494$34,617→ 22,929 total - Exercise/Conversion
Common Stock
2003-12-01$9.80/sh+5,625$55,125→ 28,554 total - Sale
Common Stock
2003-12-01$13.88/sh−5,625$78,076→ 22,929 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-12-01−2,494→ 0 totalExercise: $9.21From: 1995-05-25Exp: 2004-05-24→ Common Stock (2,494 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-12-01−5,625→ 0 totalExercise: $9.80From: 1995-05-25Exp: 2004-05-25→ Common Stock (5,625 underlying)